NLME (Non-Linear Mixed Effects) Archives

Video

Today’s drug candidates are more complex than ever. But with development decisions on the line,…

CertaraFebruary 12, 2025

Publication

CS-8635, a fixed-dose triple combination of olmesartan, amlodipine, and hydrochlorothiazide, was developed to address the…

CertaraApril 1, 2013

Publication

Reviews of the productivity of the pharmaceutical industry have concluded that the current business model…

CertaraNovember 18, 2011

NLME (Non-Linear Mixed Effects)